Lukas M, Kolar M, Reissigova J, Duricova D, et al. A switch from originator-adalimumab to the biosimilar SB5 in patients with Crohn's disease: an analysis of two propensity score-matched cohorts. Scand J Gastroenterol 2022;57:814-824.
PMID: 35234552